Department of Internal Medicine, Division of Cardiovascular Medicine (E.D.S., P.A., A.S.H.), University of Michigan, Ann Arbor.
Cardiovascular Genetics Program, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (N.K.L., K.N.).
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
Mutations in desmoplakin (), the primary force transducer between cardiac desmosomes and intermediate filaments, cause an arrhythmogenic form of cardiomyopathy that has been variably associated with arrhythmogenic right ventricular cardiomyopathy. Clinical correlates of cardiomyopathy have been limited to small case series.
Clinical and genetic data were collected on 107 patients with pathogenic mutations and 81 patients with pathogenic plakophilin 2 () mutations as a comparison cohort. A composite outcome of severe ventricular arrhythmia was assessed.
and cohorts included similar proportions of probands (41% versus 42%) and patients with truncating mutations (98% versus 100%). Left ventricular (LV) predominant cardiomyopathy was exclusively present among patients with (55% versus 0% for , <0.001), whereas right ventricular cardiomyopathy was present in only 14% of patients with versus 40% for (<0.001). Arrhythmogenic right ventricular cardiomyopathy diagnostic criteria had poor sensitivity for cardiomyopathy. LV late gadolinium enhancement was present in a primarily subepicardial distribution in 40% of patients with (23/57 with magnetic resonance images). LV late gadolinium enhancement occurred with normal LV systolic function in 35% (8/23) of patients with . Episodes of acute myocardial injury (chest pain with troponin elevation and normal coronary angiography) occurred in 15% of patients with and were strongly associated with LV late gadolinium enhancement (90%), even in cases of acute myocardial injury with normal ventricular function (4/5, 80% with late gadolinium enhancement). In 4 cases with 18F-fluorodeoxyglucose positron emission tomography scans, acute LV myocardial injury was associated with myocardial inflammation misdiagnosed initially as cardiac sarcoidosis or myocarditis. Left ventricle ejection fraction <55% was strongly associated with severe ventricular arrhythmias for cases (<0.001, sensitivity 85%, specificity 53%). Right ventricular ejection fraction <45% was associated with severe arrhythmias for cases (<0.001) but was poorly associated for cases (=0.8). Frequent premature ventricular contractions were common among patients with severe arrhythmias for both (80%) and (91%) groups (=non-significant).
cardiomyopathy is a distinct form of arrhythmogenic cardiomyopathy characterized by episodic myocardial injury, left ventricular fibrosis that precedes systolic dysfunction, and a high incidence of ventricular arrhythmias. A genotype-specific approach for diagnosis and risk stratification should be used.
桥粒芯蛋白()中的突变是心脏桥粒与中间丝之间的主要力传感器,可导致心律失常形式的心肌病,该心肌病与致心律失常性右室心肌病(arrhythmogenic right ventricular cardiomyopathy,ARVC)有不同程度的关联。对 心肌病的临床相关性的研究仅限于小的病例系列。
对 107 例携带致病性 突变和 81 例携带致病性桥粒斑蛋白 2()突变的患者(作为比较队列)进行临床和遗传数据收集。评估严重室性心律失常的复合结局。
和 两组的先证者比例(41%对 42%)和截断突变患者比例(98%对 100%)相似。左心室(left ventricular,LV)为主型心肌病仅存在于 患者中(55%对 患者为 0%,<0.001),而右心室心肌病仅存在于 患者的 14%(40%)<0.001)。致心律失常性右室心肌病的诊断标准对 心肌病的敏感性较差。LV 晚期钆增强在 40%的 患者中呈主要心外膜分布(有磁共振成像的 57 例患者中有 23 例)。LV 晚期钆增强在 35%(23 例中的 8 例)的 患者中发生在 LV 收缩功能正常的情况下。15%的 患者发生急性心肌损伤(胸痛伴肌钙蛋白升高和正常冠状动脉造影),与 LV 晚期钆增强强烈相关(90%),甚至在急性心肌损伤合并正常心室功能的情况下(4/5,80%有晚期钆增强)也是如此。在 4 例接受 18F-氟脱氧葡萄糖正电子发射断层扫描(fluorodeoxyglucose positron emission tomography,FDG-PET)扫描的患者中,急性 LV 心肌损伤与最初误诊为心脏结节病或心肌炎的心肌炎症相关。对于 病例,左心室射血分数(left ventricular ejection fraction,LVEF)<55%与严重室性心律失常强烈相关(<0.001,敏感性 85%,特异性 53%)。对于 病例,右心室射血分数(right ventricular ejection fraction,RVEF)<45%与严重心律失常相关(<0.001),但与 病例相关性差(=0.8)。对于严重心律失常的患者,频发室性早搏在 和 两组中均很常见(分别为 80%和 91%,=非显著)。
心肌病是一种心律失常性心肌病的独特形式,其特征为间歇性心肌损伤、左心室纤维化先于收缩功能障碍以及室性心律失常发生率高。应采用基于基因类型的诊断和风险分层方法。